Sign In
Buy ALDX
$1.86
+0.220 (+13.41%)
At Close: Jun 03, 2026
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immun
Aldeyra Explodes 30% After-Hours Ahead Of Covid-19 Update Today
05:48am, Wednesday, 20'th May 2020
Shares in Aldeyra Therapeutics Inc (ALDX) exploded 30% in after-hours trading on Tuesday, following news that the company will host a conference call and webcast at 8AM ET today to provide a COVID-1
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:00am, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 19)
ADC Therapeutics SA (NYSE:...
Aldeyra Therapeutics to Host Conference Call and Webcast to Provide COVID-19 Development Update
08:05pm, Tuesday, 19'th May 2020
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Wednesday, May 20, 2020 to provide a COVID-19 development update.
How Aldeyra (ALDX) Stock Stands Out in a Strong Industry
12:53pm, Friday, 15'th May 2020
Aldeyra (ALDX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Prosight Management, LP Buys Alexion Pharmaceuticals Inc, Direxion Small Cap Bear 'X Shares, ...
12:00am, Friday, 15'th May 2020Top Ranked Momentum Stocks to Buy for May 14th
02:14pm, Thursday, 14'th May 2020
Top Ranked Momentum Stocks to Buy for May 14th
Aldeyra Therapeutics Inc (ALDX) Upgraded to Strong Buy: Here's What You Should Know
04:00pm, Wednesday, 13'th May 2020
Aldeyra Therapeutics Inc (ALDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Aldeyra's Shares March Higher, Can It Continue?
12:17pm, Wednesday, 13'th May 2020
As of late, it has definitely been a great time to be an investor in Aldeyra Therapeutics.
